Danaher Corp (NYSE: DHR) President and Chief Executive Officer Rainer Blair sold 58,255 shares of common stock on August 21, 2026, for approximately $12.7 million, according to regulatory filings.
The transactions were executed in three blocks at weighted average prices ranging from $217.77 to $219.35 per share. The first block of 11,307 shares was sold between $217.21 and $218.21, the second block of 39,193 shares between $218.21 and $219.20, and the final block of 7,755 shares between $219.23 and $219.95. Blair retained 37,988 shares held directly following the sale.
The disposals follow Danaher’s second-quarter 2026 results, which exceeded Wall Street expectations. Adjusted earnings came in at $1.94 per share, above the $1.83 consensus estimate, while revenue reached $6.3 billion, surpassing the $6.1 billion forecast. The company reaffirmed its financial guidance for the third quarter and full-year 2026 without modification.
Leadership transition plans remain on track, with Julie Sawyer Montgomery set to assume the CEO role effective October 1, 2026, succeeding Blair.
Analysts adjusted price targets following the results. TD Cowen lowered its target to $236 while maintaining a Buy rating. Guggenheim reduced its target to $200, also keeping a Buy rating. Stifel cut its target to $220, maintaining a Buy rating but citing concerns over underperformance in the bioprocess business. Investors have expressed caution over guidance stability and delays in bioproduction timelines, driven by commercial customers postponing large resin purchases.
